Daejeon, South Korea

Yeong Bong Mok

This inventor holds 9 USPTO granted patents and 5 published patent applications and 5 EPO patents. Top assignee: Lg Chem, Ltd. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yeong Bong Mok. Retrieved from https://idiyas.com/inventor/yeong-bong-mok

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 77.8

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yeong Bong Mok

Introduction: Yeong Bong Mok, a pioneering inventor hailing from Daejeon, South Korea, has made significant contributions to the field of technology with his groundbreaking inventions.

Latest Patents: Yeong Bong Mok holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: Throughout his illustrious career, Yeong Bong Mok has been recognized for his inventive prowess, receiving numerous awards for his groundbreaking technologies that have revolutionized various industries.

Collaborations: Yeong Bong Mok has collaborated with leading research institutions, universities, and tech companies worldwide, fostering a culture of innovation and knowledge-sharing to drive progress in the field of technology.

Conclusion: Yeong Bong Mok's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to dream big and create a better future through technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…